The global intravenous (IV) system access devices market is becoming an essential pillar of modern healthcare, offering critical solutions for the efficient and reliable administration of medications, fluids, and nutrients directly into the bloodstream. The market was valued at approximately USD 19 billion in 2022 and is expected to reach nearly USD 35 billion by 2030, growing at...
English
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian